- Report
- April 2023
- 130 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 111 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- August 2022
- 120 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- August 2022
- 120 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- February 2024
- 120 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- April 2023
- 110 Pages
Global
From €4222EUR$4,750USD£3,655GBP
- Report
- July 2024
- 180 Pages
Global
From €2222EUR$2,500USD£1,924GBP
- Report
- May 2024
- 140 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- June 2023
- 76 Pages
Europe
From €1333EUR$1,500USD£1,154GBP
- Report
- April 2023
- 326 Pages
Global
From €3200EUR$3,600USD£2,770GBP
- Report
- November 2022
- 206 Pages
Global
From €3200EUR$3,600USD£2,770GBP
- Report
- January 2024
- 70 Pages
North America
From €3066EUR$3,450USD£2,655GBP
- Report
- October 2023
- 152 Pages
Global
From €3164EUR$3,560USD£2,739GBP
€3955EUR$4,450USD£3,424GBP
- Report
- July 2023
- 121 Pages
Asia Pacific
From €1333EUR$1,500USD£1,154GBP
- Report
- July 2023
- 151 Pages
Asia Pacific
From €1333EUR$1,500USD£1,154GBP
- Report
- June 2023
- 72 Pages
North America
From €1333EUR$1,500USD£1,154GBP
- Report
- September 2018
- 162 Pages
Global
From €7106EUR$7,995USD£6,152GBP
- Report
- February 2024
- 180 Pages
Global
From €4416EUR$4,969USD£3,824GBP
- Report
- April 2023
- 147 Pages
Global
From €4399EUR$4,949USD£3,808GBP
- Report
- May 2023
- 169 Pages
Global
From €7106EUR$7,995USD£6,152GBP

Cancer Immunotherapy is a type of Immune Disorders Drugs that uses the body's own immune system to fight cancer. It works by stimulating the body's natural defense system to recognize and attack cancer cells. This type of therapy is used to treat a variety of cancers, including melanoma, lymphoma, and leukemia. It can also be used to treat other types of cancer, such as breast, lung, and colorectal cancer.
Cancer Immunotherapy is a rapidly growing field, with many new treatments being developed. It is an important part of the overall cancer treatment landscape, as it can provide a more targeted approach to treating cancer. It can also be used in combination with other treatments, such as chemotherapy and radiation therapy, to improve outcomes.
Some of the companies in the Cancer Immunotherapy market include Merck, Bristol-Myers Squibb, AstraZeneca, Novartis, and Roche. These companies are developing a range of treatments, including monoclonal antibodies, vaccines, and cell-based therapies. Show Less Read more